Neuropsychiatric Burden in Huntington’s Disease

By Paoli Ricardo Augusto   Botturi Andrea   Ciammola Andrea   Silani Vincenzo   Prunas Cecilia   Lucchiari Claudio   Zugno Elisa   Caletti Elisabetta  

Brain Sciences, Vol. 7, Iss. 6, 2017-06 ,pp. : 67-67

MDPI

Access to resources Recommend Favorite

Improvement of Advanced Parkinson’s Disease Manifestations with Deep Brain Stimulation of the Subthalamic Nucleus: A Single Institution Experience

By Rabie Ahmed   Verhagen Metman Leo   Fakhry Mazen   Eassa Ayman Youssef Ezeldin   Fouad Wael   Shakal Ahmed   Slavin Konstantin V.  

Brain Sciences, Vol. 6, Iss. 4, 2016-12 ,pp. : 58-58

MDPI

Access to resources Recommend Favorite

Use of Genetically Altered Stem Cells for the Treatment of Huntington’s Disease

By Crane Andrew T.   Rossignol Julien   Dunbar Gary L.  

Brain Sciences, Vol. 4, Iss. 1, 2014-03 ,pp. : 202-219

MDPI

Access to resources Recommend Favorite

Striatal Vulnerability in Huntington’s Disease: Neuroprotection Versus Neurotoxicity

By Morigaki Ryoma   Goto Satoshi  

Brain Sciences, Vol. 7, Iss. 6, 2017-06 ,pp. : 63-63

MDPI

Access to resources Recommend Favorite

Effects of a Sativex-Like Combination of Phytocannabinoids on Disease Progression in R6/2 Mice, an Experimental Model of Huntington’s Disease

By Valdeolivas Sara   Sagredo Onintza   Delgado Mercedes   Pozo Miguel A.   Fernández-Ruiz Javier  

International Journal of Molecular Sciences, Vol. 18, Iss. 4, 2017-03 ,pp. : 684-684

MDPI

Access to resources Recommend Favorite